5-S-Cysteinyl-dopamine effect on the human dopaminergic neuroblastoma cell line SH-SY5Y

Neurochemistry International

Volumn 49, Issue 3, 2006, Pages 262-269

  Mosca, Luciana ^a   Lendaro, Eugenio ^a   d'Erme, Maria ^a   Marcellini, Sonia ^b   Moretti, Sonia ^b   Rosei, Maria Anna ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

5 S Cysteinyl dopamine; Catechol thioethers; Neurodegeneration; Oxidative stress; Parkinson's disease; SH SY5Y

Indexed keywords

CASPASE 3 LIKE PROTEASE; CYSTEINYLDOPA; DNA FRAGMENT; GLUTATHIONE; PEROXIDE; PROTEINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEUROBLASTOMA;

EID: 33745660070     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.01.023     Document Type: Article

References (32)

1. +. Exp. Neurol. 181 (2003) 25-38
2. Budd S.L., Castilho R.F., and Nicholls D.G. Mitochondrial membrane potential and hydroethidine-monitored superoxide generation in cultured cerebellar granule cells. FEBS Lett. 415 (1997) 21-24
3. Carstam R., Brinck C., Hindemith-Augustsson A., Rorsman H., and Rosengren E. The neuromelanin of the human Substantia Nigra. Biochim. Biophys. Acta 1097 (1991) 52-60
4. Cheng F.C., Kuo J.S., Chia L.G., and Dryhurst G. Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease. J. Neural. Transm. 103 (1996) 433-446
5. Chioccara F., and Novellino E. A convenient one step synthesis of 5-cystein-S-yldopa using ceric ammonium nitrate. Synth. Commun. 16 (1986) 967-971
6. Ciriolo M.R., Aquilano K., De Martino A., Carrì M.T., and Rotilio G. Differential role of superoxide and glutathione in S-nitrosoglutathione-mediated apoptosis: a rationale for mild forms of familial amyotrophic lateral sclerosis associated with less active Cu, Zn superoxide dismutase mutants. J. Neurochem. 77 (2001) 1433-1443
7. Delneste Y., Jeannin P., Sebille E., Aubry J.P., and Bonnefoy J.Y. Thiols prevent Fas (CD95)-mediated T cell apoptosis by down-regulating membrane Fas expression. Eur J. Immunol. 26 (1996) 2981-2988
8. Dringen R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 62 (2000) 649-671
9. Fornstedt B., Brun A., Rosengren E., and Carlsson A. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J. Neural. Transm. Park. Dis. Dement. Sect. 1 (1989) 279-295
10. Gomez C., Reiriz J., Piqué M., Gil J., Ferrer I., and Ambrosio S. Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells. J. Neurosci. Res. 63 (2001) 421-428
11. Gomez-Santos C., Ferrer I., Santidrian A.F., Barrachina M., Gil J., and Ambrisio S. Dopamine induces autophagic cell death and α-synuclein increase in human neuroblastoma SH-SY5Y cells. J. Neurosci. Res. 73 (2003) 341-350
12. Hampton M.B., and Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis. FEBS Lett. 414 (1997) 552-556
13. Hope A.D., De Silva R., Fischer D.F., Hol E.M., Van Leeuwen F.W., and Lees A.J. Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression. J. Neurochem. 86 (2003) 394-404
14. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 (2003) S26-S36
15. Lai C.T., and Yu P.H. Dopamine- and l-β-3,4-dihydroxyphenylalanine hydrochloride (l-DOPA)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Biochem. Pharmacol. 53 (1997) 363-372
16. Li H., and Dryhurst G. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease. J. Neurochem. 69 (1997) 1530-1541
17. Li H., Shen X.M., and Dryhurst G. Brain mitochondrial catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenesis of Parkinson's disease. J. Neurochem. 71 (1998) 2049-2062
18. Montine K.S., Sidell K.R., Zhang J., and Montine T.J. Dopamine thioethers: formation in brain and neurotoxicity. Neurotoxicity Res. 4 (2002) 663-669
19. Odh G., Carstam R., Paulson J., Wittbjer A., Rosengren E., and Rorsman H. Neuromelanin of the human substantia nigra: a mixed-type melanin. J. Neurochem. 62 (1994) 2030-6030
20. Olanow C.W., and Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22 (1999) 123-144
21. Picklo M.J., Amarnath V., Graham D.G., and Montine T.J. Endogenous catechol thioethers may be pro-oxidant or antioxidant. Free Radic. Biol. Med. 27 (1999) 271-277
22. Sidell K.R., Amarnath V., and Montine T. Dopamine thioethers in neurodegeneration. Curr. Topics Med. Chem. 1 (2001) 519-527
23. Sidell K.R., Olson S.J., Ou J.J., Zhang Y., Amarnath V., and Montine T.J. Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo. J. Neurochem. 79 (2001) 510-521
24. Sofic E., Lange K.W., Jellinger K., and Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142 (1992) 128-130
25. Spencer J.P.E., Jenner P., Daniel S.E., Lees A.J., Marsden D.C., and Halliwell B. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species. J. Neurochem. 71 (1998) 2112-2122
26. Spencer J.P.E., Whiteman M., Jenner P., and Halliwell B. 5-S-cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. J. Neurochem. 81 (2002) 122-129
27. Tatton N.A., Maclean-Fraser A., Tatton W.G., Perl D.P., and Olanow C.W. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann. Neurol. 44 (1998) S142-S148
28. Tatton W.G., Chalmers-Redman R., Brown D., and Tatton N. Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann. Neurol. 53 (2003) S61-S70
29. m-dependent and -independent production of reactive oxygen species by rat brain mitochondria. J. Neurochem. 79 (2001) 266-277
30. Zecca L., Mecacci C., Seraglia R., and Parati E. The chemical characterization of melanin contained in substantia nigra of human brain. Biochim. Biophys. Acta 1138 (1992) 6-10
31. Zhang F., and Dryhurst G. Effects of l-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic PD. J. Med. Chem. 37 (1994) 1084-1098
32. Zhang J., Kravtsov V., Amarnath V., Picklo M.J., Graham D.G., and Montine T.J. Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease. J. Neurochem. 74 (2000) 970-978